

Clinical Data, Inc. to Present at Upcoming Investor Conferences
NEWTON, Mass.--([ BUSINESS WIRE ])--[ Clinical Data, Inc. ] (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at three investor conferences:
- Wedbush Securities Life Sciences Best Ideas MAC Conference on Tuesday, August 3, 2010 at 3:00 p.m. at Le Parker Meridien Hotel, New York, NY
- BMO Capital Markets 10th Annual Focus on Healthcare Conference on Thursday, August 5, 2010 at 9:00 a.m. at the Sheraton New York Hotel & Towers, New York, NY
- Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference on Friday, August 13, 2010 at 9:20 a.m. at The Southampton Inn, Southampton, NY
A live audio and archived webcast of the Companya�s presentation can be accessed through Clinical Data's website at [ www.clda.com ].
About Clinical Data, Inc.
Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for [ central nervous system disorders ] and [ cardiovascular diseases ], to be followed by promising drug candidates in other major therapeutic areas. Clinical Data combines its drug development and biomarker expertise in an effort to develop products with enhanced efficacy and tolerability to improve patient health and reduce costs. To learn more, please visit the Company's website at [ www.clda.com ].